228
Views
44
CrossRef citations to date
0
Altmetric
Review

Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors

Pages 111-118 | Published online: 10 Jan 2014

References

  • Fisher RS. Epilepsy from the patient’s perspective: review of results of a community-based survey. Epilepsy Behav. 1, S9–S14 (2000).
  • Tettenborn B, Kramer G. Total patient care in epilepsy. Epilepsia 33(Suppl. 1), S28–S32 (1992).
  • Schachter SC. Advances in the assessment of refractory epilepsy. Epilepsia 34(Suppl. 5), S24–S30 (1993).
  • Birbeck GL, Hays RD, Cui X, Vickrey BG. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 43, 535–538 (2002).
  • Baker GA, Gagnon D, McNulty P. The relationship between seizure frequency, seizure type and quality of life: findings from three European countries. Epilepsy Res. 30, 231–240 (1998).
  • Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 38, 353–362 (1997).
  • Au A, Li P, Chan J et al. Predicting the quality of life in Hong Kong Chinese adults with epilepsy. Epilepsy Behav. 3, 50–357 (2002).
  • Baker GA, Spector S, McGrath Y, Soteriou H. Impact of epilepsy in adolescence: a UK controlled study. Epilepsy Behav. 6, 556–562 (2005).
  • Jacoby A, Snape D, Baker GA. Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurol. 4, 171–178 (2005).
  • Nubukpo P, Clement JP, Houinato D et al. Psychosocial issues in people with epilepsy in Togo and Benin (West Africa) II: quality of life measured using the QOLIE-31 scale. Epilepsy Behav. 5, 728–734 (2004).
  • Finelli PF, Cardi JK. Seizure as a cause of fracture. Neurology 39, 858–860 (1989).
  • Annegers JF, Melton LJ, Sun C-A, Hauser WA. Risk of age-related fractures in patients with unprovoked seizures. Epilepsia 30, 348–355 (1989).
  • Spitz MC, Towbin JA, Shantz D, Adler LE. Risk factors for burns as a consequence of seizures in persons with epilepsy. Epilepsia 35, 764–767 (1994).
  • Kirby S, Sadler RM. Injury and death as a result of seizures. Epilepsia 36, 25–28 (1995).
  • Derby LE, Tennis P, Jick H. Sudden unexplained death among subjects with refractory epilepsy. Epilepsia 37, 931–935 (1996).
  • Baker GA, Nashef L, van Hout BA. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality. Epilepsia 38(Suppl. 1), S1–8 (1997).
  • Jones MW. Consequences of epilepsy: why do we treat seizures? Can. J. Neurol. Sci. 25, S24–S26 (1998).
  • May TW, Pfafflin M. The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled, randomized study. Epilepsia 43, 539–549 (2002).
  • Schachter SC, Shafer PO, Murphy W. The personal impact of seizures: correlations with seizure frequency, employment, cost of medical care, and satisfaction with physician care. J. Epilepsy 6, 224227 (1993).
  • Legion V. Health education for self-management by people with epilepsy. J. Neurosci. Nurs. 23, 300–305 (1991).
  • Yagi K. Epilepsy: comprehensive care, quality of life, and factors preventing people with epilepsy from being employed. Clin. Ther. 20(Suppl. A), A19–A29 (1998).
  • Kellett MW, Smith DF, Baker GA, Chadwick DW. Quality of life after epilepsy surgery. J. Neurol. Neurosurg. Psychiatry. 63, 52–58 (1997).
  • Cooper M. Epilepsy and employment-employers’ attitudes. Seizure 4, 193–199 (1995).
  • Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics 20, 10391059 (2002).
  • Selai C, Bannister D, Trimble M. Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy. Epilepsia 46(Suppl. 4), 50–57 (2005).
  • Reijs R, Aldenkamp AP, De Krom M. Mood effects of antiepileptic drugs. Epilepsy Behav. 5(Suppl. 1), S66–S76 (2004).
  • Wilby J, Kainth A, Hawkins N et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Pharmacoeconomics 9, 1–157 (2005).
  • Pirio Richardson S, Farias ST, Lima III AR, Alsaadi TM. Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy. Epilepsy Behav. 5, 343–347 (2004).
  • Miller V, Palermo TM, Grewe SD. Quality of life in pediatric epilepsy: demographic and disease-related predictors and comparison with healthy controls. Epilepsy Behav. 4, 36–42 (2003).
  • Pellock JM, Smith MC, Cloyd JC, Uthman B, Wilder BJ. Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy. Epilepsy Behav. 5, 301–307 (2004).
  • Baker GA, Hesdon B, Marson AG. Quality of life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 41, 1357–1363 (2000).
  • Boro A, Haut S. Medical comorbidities in the treatment of epilepsy. Epilepsy Behav. 4(Suppl. 2), 2–12 (2003).
  • Alanis-Guevara I, Pena E, Corona T, Lopez-Ayala T, Lopez-Meza E, Lopez-Gomez M. Sleep disturbances, socioeconomic status, and seizure control as main predictors of quality of life in epilepsy. Epilepsy Behav. 7, 481–485 (2005).
  • Szaflarski JP, Szaflarski M. Seizure disorders, depression, and health-related quality of life. Epilepsy Behav. 5, 50–57 (2004).
  • de Weerd A, de Haas S, Otte A et al. Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia 45, 1397–1404 (2004).
  • Devinsky O. The meaning of quality of life to patients with epilepsy. Epilepsy Behav. 1(Suppl. 1), S18–S20 (2000).
  • Leidy NK, Rentz AM, Grace EM. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy. Epilepsia 39, 965–977 (1998).
  • Langfitt JT. Comparison of the psychometric characteristics of three quality of life measures in intractable epilepsy. Qual. Life Res. 4, 101114 (1995).
  • Devinsky O, Vickrey BG, Cramer J et al. Development of the quality of life in epilepsy inventory. Epilepsia 36, 1089–1104 (1995).
  • Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res. 16, 65–81 (1993).
  • Vickrey BG, Hays RD, Graber J, Rausch R, Engel J, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med. Care 30, 299–319 (1992).
  • Dodrill CB, Batzel LW, Queisser HR, Temkin NR. An objective method for the assessment of psychological and social problems among epileptics. Epilepsia 21, 123–135 (1980).
  • Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38, 233–236 (1997).
  • Loring DW, Larrabee GJ, Meador KJ, Lee GP. Dimensions of the Epilepsy Foundation concerns index. Epilepsy Behav. 6, 348–352 (2005).
  • Au A, Chan F, Li K, Leung P, Li P, Chan J. Cognitive-behavioral group treatment program for adults with epilepsy in Hong Kong. Epilepsy Behav. 4, 441–446 (2003).
  • Sabaz M, Lawson JA, Cairns DR et al. Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients. Epilepsy Behav. 4, 680–691 (2003).
  • Yam WKL, Chow SMK, Ronen GM. Chinese version of the parent-proxy health-related quality of life measure for children with epilepsy: translation, cross-cultural adaptation, and reliability studies. Epilepsy Behav. (In Press) (2005).
  • Batzel LW, Dodrill CB, Dubinsky BL et al. An objective method for the assessment of psychosocial problems in adolescents with epilepsy. Epilepsia 32, 202–211 (1991).
  • Engelberts NHJ, Klein M, van der Ploeg HM, Heimans JJ, Jolles J, Kasteleijn-Nolst Trenite DGA. Cognition and health-related quality of life in chronic well-controlled patients with partial epilepsy on carbamazepine monotherapy. Epilepsy Behav. 3, 316–321 (2002).
  • Fritz N, Glogau S, Hoffmann J, Rademacher M, Elger CE, Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav. 6, 373–381 (2005).
  • Cramer JA, Hammer AE, Kustra RP. Improved mood states with lamotrigine in patients with epilepsy. Epilepsy Behav. 5, 702–707 (2004).
  • Cramer JA, Van Hammee G. Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy Behav. 4, 118–123 (2003).
  • Ergene E, Behr PK, Shih JJ. Quality-of-life assessment in patients treated with vagus nerve stimulation. Epilepsy Behav. 2, 284–287 (2001).
  • Vickrey BG, Hays RD, Engel J Jr et al. Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann. Neurol. 37, 158166 (1995).
  • McLachlan RS, Rose KJ, Derry PA, Bonnar C, Blume WT, Girvin JP. Health-related quality of life and seizure control in temporal lobe epilepsy. Ann. Neurol. 41, 482489 (1997).
  • Malmgren K, Sullivan M, Ekstedt G, Kullberg G, Kumlien E. Health-related quality of life after epilepsy surgery: a Swedish multicenter study. Epilepsia 38, 830–838 (1997).
  • Aydemir N, Ozkara Ccd, Canbeyli R, Tekcan A. Changes in quality of life and self-perspective related to surgery in patients with temporal lobe epilepsy. Epilepsy Behav. 5, 735–742 (2004).
  • Cankurtaran ES, Ulug B, Saygi S, Tiryaki A, Akalan N. Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy. Epilepsy Behav. 7, 116–122 (2005).
  • Reid K, Herbert A, Baker GA. Epilepsy surgery: patient-perceived long-term costs and benefits. Epilepsy Behav. 5, 81–87 (2004).
  • Mikati MA, Comair Y, Ismail R, Faour R, Rahi AC. Effects of epilepsy surgery on quality of life: a controlled study in a Middle Eastern population. Epilepsy Behav. 5, 72–80 (2004).
  • Helgeson DC, Mittan R, Tan SY, Chayasirisobhon S. Sepulveda epilepsy education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia 31, 75–82 (1990).
  • Lee MMK, Lee TMC, Ng PKK, Hung ATF, Au AML, Wong VCN. Psychosocial well-being of carers of people with epilepsy in Hong Kong. Epilepsy Behav. 3, 147–157 (2002).
  • Elliott IM, Lach L, Smith ML. Adolescent and maternal perspectives of quality of life and neuropsychological status following epilepsy surgery. Epilepsy Behav. 1, 406–417 (2000).
  • Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch. Neurol. 43, 766–770 (1986).
  • O’Donoghue MF, Goodridge DM, Redhead K, Sander JW, Duncan JS. Assessing the psychosocial consequences of epilepsy: a community-based study. Br. J. Gen. Pract. 49, 211–214 (1999).
  • Kanner AM, Barry JJ. The impact of mood disorders in neurological diseases: should neurologists be concerned? Epilepsy Behav. 4(Suppl. 3), 3–13 (2003).
  • Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs. 16, 291–302 (2002).
  • Gilliam F, Kanner AM. Treatment of depressive disorders in epilepsy patients. Epilepsy Behav. 3(5 Suppl. 1), 2–9 (2002).
  • Hermann BP, Seidenberg M, Bell B, Woodard A, Rutecki P, Sheth R. Comorbid psychiatric symptoms in temporal lobe epilepsy: association with chronicity of epilepsy and impact on quality of life. Epilepsy Behav. 1, 184–190 (2000).
  • Perrine K, Hermann BP, Meador KJ et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch. Neurol. 52, 997–1003 (1995).
  • Lehrner J, Kalchmayr R, Serles W et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 8, 88–92 (1999).
  • Attarian H, Dowling J, Carter J, Gilliam F. Video EEG monitoring prior to vagal nerve stimulator implantation. Neurology 61, 402–403 (2003).
  • Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 58(8 Suppl. 5), S9–S20 (2002).
  • Devinsky O, Vickrey BG, Cramer J et al. Development of the quality of life in epilepsy inventory. Epilepsia 36, 1089–1104 (1995).
  • Loring DW, Meador KJ, Lee GP. Determinants of quality of life in epilepsy. Epilepsy Behav. 5, 976–980 (2004).
  • Cramer JA, Blum D, Reed M, Fanning K. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav. 4, 515–521 (2003).
  • Barry JJ, Jones JE. What is effective treatment of depression in people with epilepsy? Epilepsy Behav. 6, 520–528 (2005).
  • Kanner AM, Balabanov AJ. Pharmacotherapy of mood disorders in epilepsy: the role of newer psychotropic drugs. Curr. Treat. Options Neurol. 7, 281–290 (2005).
  • Vazquez B, Devinsky O. Epilepsy and anxiety. Epilepsy Behav. 4(Suppl. 4), S20–S25 (2003).
  • Beyenburg S, Mitchell AJ, Schmidt D, Elger CE, Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav. 7, 161–171 (2005).
  • Goldstein MA, Harden CL. Epilepsy and anxiety. Epilepsy Behav. 1, 228–234 (2000).
  • Wilson SJ, Bladin PF, Saling MM. Paradoxical results in the cure of chronic illness: the ‘burden of normality’ as exemplified following seizure surgery. Epilepsy Behav. 5, 13–21 (2004).
  • Cramer JA, Brandenburg N, Xu X. Differentiating anxiety and depression symptoms in patients with partial epilepsy. Epilepsy Behav. 6, 563–569 (2005).
  • Fisher RS, Vickrey BG, Gibson P et al. The impact of epilepsy from the patient’s perspective I. Descriptions and subjective perceptions. Epilepsy Res. 41, 39–51 (2000).
  • Fisher RS, Vickrey BG, Gibson P et al. The impact of epilepsy from the patient’s perspective II: views about therapy and healthcare. Epilepsy Res. 41, 53–61 (2000).
  • Gilliam F, Kuzniecky R, Meador K et al. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology 53, 687–694 (1999).
  • Gunter MJ, Brixner D, von Worley A, Carter S, Gregory C. Impact of a seizure disorder management program on patient-reported quality of life. Dis. Manag. 7, 333–347 (2004).
  • Watson D, Friend R. Measurement of social-evaluative anxiety. J. Consult. Clin. Psychol. 33, 448–457 (1969).
  • Richardson DW, Friedman SB. Psychosocial problems of the adolescent patient with epilepsy. Clin. Pediatr. 13, 121–126 (1974).
  • Cramer JA, Westbrook L, Devinksy O, Perrine K, Glassman M, Camfield C. Development of a quality of life inventory for adolescents: the QOLIE-AD-48. Epilepsia 40, 1114–1121 (1999).
  • Snead K, Ackerson J, Bailey K, Schmitt MM, Madan-Swain A, Martin RC. Taking charge of epilepsy: the development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents. Epilepsy Behav. 5, 547–556 (2004).
  • Williams J, Steel C, Sharp GB et al. Parental anxiety and quality of life in children with epilepsy. Epilepsy Behav. 4, 483–486 (2003).
  • Lewis MA, Hatton CL, Salas I, Chiofalo N. Impact of the children’s epilepsy program on parents. Epilepsia 32, 365–374 (1991).
  • Jacoby A. Stigma, epilepsy, and quality of life. Epilepsy Behav. 3(6 Suppl. 2), 10–20 (2002).
  • Morrell MJ. Stigma and epilepsy. Epilepsy Behav. 3(6 Suppl. 2), 21–25 (2002).
  • MacLeod JS, Austin JK. Stigma in the lives of adolescents with epilepsy: a review of the literature. Epilepsy Behav. 4, 112–117 (2003).
  • McLin WM, de Boer HM. Public perceptions about epilepsy. Epilepsia 36, 957–959 (1995).
  • Khan A, Huerter V, Sheikh SM, Thiele EA. Treatments and perceptions of epilepsy in Kashmir and the United States: a cross-cultural analysis. Epilepsy Behav. 5, 580–586 (2004).
  • Meinardi H, Scott RA, Reis R, Sander JW. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 42, 136–149 (2001).
  • Jacoby K, Jacoby A. Epilepsy and insurance in the UK: an exploratory survey of the experiences of people with epilepsy. Epilepsy Behav. 5, 884–893 (2004).
  • De Boer HM. Overview and perspectives of employment in people with epilepsy. Epilepsia 46(Suppl. 1), 52–54 (2005).
  • Baker GA. People with epilepsy: what do they know and understand, and how does this contribute to their perceived level of stigma? Epilepsy Behav. 3(6 Suppl. 2), 26–32 (2002).
  • Rosenberg M. Society and the adolescent self-image. Princeton Univ. Press, NJ, USA (1965).
  • Anderson GD, Kim H, Warner MH. Impact of taking antiepileptic drugs at school in a group of children and adolescents. Epilepsy Behav. 1, 17–21 (2000).
  • Amir M, Roziner I, Knoll A, Neufeld MY. Self-efficacy and social support as mediators in the relation between disease severity and quality of life in patients with epilepsy. Epilepsia 40, 216–224 (1999).
  • Gramstad A, Iversen E, Engelsen BA. The impact of affectivity dispositions, self-efficacy and locus of control on psychosocial adjustment in patients with epilepsy. Epilepsy Res. 46, 53–61 (2001).
  • Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 39, 81–88 (1998).
  • DiIorio C, Shafer PO, Letz R, Henry TR, Schomer DL, Yeager K. Project EASE: a study to test a psychosocial model of epilepsy medication management. Epilepsy Behav. 5, 926–936 (2004).
  • Helde G, Bovim G, Brathen G, Brodtkorb E. A structured, nurse-led intervention program improves quality of life in patients with epilepsy: A randomized, controlled trial. Epilepsy Behav. 7, 451–457 (2005).
  • Morrell MJ. Caring for people with epilepsy: resources for the healthcare provider. Epilepsy Behav. 1(4 part 2), S21–S24 (2000).
  • Shafer PO. Epilepsy and seizures: advances in seizure assessment, treatment, and self-management. Nurs. Clin. North Am. 34, 743–759 (1999).
  • Martin R, Vogtle L, Gilliam F, Faught E. Health-related quality of life in senior adults with epilepsy: what we know from randomized clinical trials and suggestions for future research. Epilepsy Behav. 4, 626–634 (2003).
  • Devinsky O. Quality of life in the elderly with epilepsy. Epilepsy Behav. 6, 1–3 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.